General Information of the Compound
Compound ID |
CP0540722
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
US8551978, I-69
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C51H56N6O7
|
||||||||||||||||||
Molecular Weight |
865.044
|
||||||||||||||||||
Canonical SMILES |
C[C@@H](Cc1cccc(CNC(=O)Cc2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C51H56N6O7/c1-34(52-33-46(59)42-19-21-45(58)50-43(42)20-22-47(60)55-50)29-36-9-8-10-37(30-36)32-53-48(61)31-35-15-17-39(18-16-35)56(2)49(62)25-28-57-26-23-40(24-27-57)64-51(63)54-44-14-7-6-13-41(44)38-11-4-3-5-12-38/h3-22,30,34,40,46,52,58-59H,23-29,31-33H2,1-2H3,(H,53,61)(H,54,63)(H,55,60)/t34-,46-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
OSAFDYZMOUYANI-XFTGMPDSSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01266, Muscarinic acetylcholine receptor M3